| Objective: This study is to investigate the effects oftetrandrine (Tet) on brain cells in phenobarbital-dependant and-withdrawn rats, and explore the related mechanisms.Methods: The ratswere randomly divided into the control group, phenobarbital-dependantmodel group, and Tet-treated groups of low-, mid-, and high-dosages.Following drug withdrawn, the morphological changes of the frontal lobecells were examined by H&E staining. Immunohistochemical stainingwas applied to detect the apoptosis-related proteins of Bcl-2and Bax.RT-PCR and Western blot methods were applied to detect the mRNA andprotein expression levels of Bcl-2and Bax, respectively, in the frontallobe.Results: Our results indicated that Tet effectively reduced thewithdrawal symptoms, particularly the weight loss, inphenobarbital-dependent and-withdrawn rats, P<0.05. H&E stainingshowed that Tet significantly restored the histopathological changes inthese addicted rats, in a dose-dependent manner. Theimmunohistochemistry, RT-PCR, and Western blot analyses indicated thatTet treatment significantly increased the Bcl-2+brain cells(P<0.05), themRNA (1.38±0.19ã€1.16±0.14ã€0.96±0.09VS0.63±0.06)and proteinexpression(1.91±0.20ã€1.57±0.14ã€1.12±0.29VS0.95±0.12) levels ofBcl-2, and decreased the Bax+cells(P<0.05), the mRNA(0.55±0.06ã€0.85±0.10ã€1.06±0.12VS1.33±0.11)and protein expression(0.79±0.06ã€0.93±0.10ã€1.16±0.22VS2.52±0.21)levels of Bax, as well as elevated theratios of Bcl-2/Bax, in phenobarbital-dependent and-withdrawn rats. Tetcould inhibit the apoptosis in these addicted rats, in a dose-dependent manner(P<0.05). Conclusion:1ã€On a gradedly increased dosage scheduleof phenobarbital,Drug-admixed-food (DAF) is a feasible way to establishanimal model of phenobarbital physical dependence.2ã€Tet can alleviatethe phenobarbital withdrawal symptoms, and protect the brain cellsagainst apoptosis, which may be related to the regulation of the mRNAand protein expression levels of Bcl-2and Bax. |